Project Details
Description
1. Build the infrastructure for genetic testing on a large scale for targeted pathogenic LRRK2 and GBA
mutations.
2. Offer telegenetics nationally for LRRK2 and GBA genetic testing for both unaffected and affected
individuals with relevant genetic risk factors.
3. Establish an infrastructure for education of community neurologists and the PD patient community
on the availability of targeted PD genetic testing focusing on “druggable” targets (LRRK2 and GBA).
4. Pilot an infrastructure focusing in Chicago initially on community-based neurologists that will collect
and process samples and return mutation testing results (LRRK2 and GBA) to their PD patients.
5. Prepare to expand the infrastructure to a national level to support genetic testing by neurologists
and other specialists providing care in the community to PD patients.
Status | Finished |
---|---|
Effective start/end date | 5/1/19 → 7/31/22 |
Funding
- Michael J. Fox Foundation for Parkinson's Research (18240)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.